HEXO - CEO, Scott Cooper.
CEO, Scott Cooper.
Source: Truss Beverages.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Sebastien St-Louis has resigned from HEXO’s board
  • He has been replaced by President and CEO, Scott Cooper, who will take on the role of Director
  • The company’s share price is down approximately 50 per cent over the past three months
  • HEXO is an award-winning licensed producer of innovative products for the global cannabis market
  • HEXO (HEXO) is up by 3.64 per cent and is currently trading at $1.71 per share

Sebastien St-Louis has resigned from HEXO’s (HEXO) board and has been replaced by President and CEO, Scott Cooper.

St-Louis recently resigned from his post as CEO following activist shareholder Adam Arviv’s allegations of mismanagement and excessive shareholder dilution.

He was promptly replaced by Cooper, a veteran in the consumer packaged goods space.

The company’s share price is down approximately 50 per cent over the past three months.

Dr. Michael Munzar, HEXO’s Chair of the Board, stated,

“I would like to take this opportunity to thank Sebastien for over eight years of service on HEXO’s Board of Directors. Through his years of dedication, he has helped build HEXO into a market leader in Canada.

It is my pleasure to welcome HEXO’s President and CEO, Scott Cooper, to the HEXO Board. Scott’s experience with Truss, Molson Coors and several other publicly-traded consumer packaged goods companies will be instrumental to HEXO’s success as we continue to drive growth and profitability through the commercialization of advanced cannabis products and to defend our position as a market leader in Canada.”

HEXO is an award-winning licensed producer of innovative products for the global cannabis market.

HEXO (HEXO) is up by 3.64 per cent and is currently trading at $1.71 per share as of 9:30 am ET.

More From The Market Herald

" Africa Oil holding renews key oil mining license

Africa Oil holding Prime Oil & Gas has renewed oil mining license (OML) 130 in Nigeria for 20 years.
Neuralink - Founder, Elon Musk.

" Neuralink brain chips approved for human trials

Elon Musk’s Neuralink, a brain implant firm, has received regulatory approval for U.S. human trials.

" @ the Bell: TSX snaps three-day losing skid

After a series of sessions in the red, Canada’s main stock index closed out Friday trading in the green as commodity prices nudged